Wikidata

(Q63320905)

English

The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

clinical trial

In more languages

Statements

short name
BLAZE (English)
0 references
title
A Multicenter, Randomized, Blinded, Double-dummy, Placebo-controlled, 3-period Cross-over Study to Evaluate the Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active Control (English)
0 references
medical condition
dyspnea
0 references
sponsor
Novartis
0 references
country
Belgium
0 references
Canada
0 references
Germany
0 references
Spain
0 references
United Kingdom
0 references
start time
October 2011
0 references
end time
August 2012
0 references
number of participants
247
0 references
research site
Novartis
0 references
minimum age
40 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63320905&oldid=1857134000"